Pilar Azevedo

Standards for the care of people with cystic fibrosis (CF); recognising and addressing CF health issues

Pierre‐Régis Burgel, Kevin W Southern, C. Addy et al. · Journal of Cystic Fibrosis · 2024 · 64 citations · Full text

Safety and efficacy of vanzacaftor–tezacaftor–deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials

Ahmet Uluer, Gordon MacGregor, Pilar Azevedo et al. · The Lancet Respiratory Medicine · 2023 · 61 citations · Full text

Medicine, Phase 2

Serum proteomics signature of Cystic Fibrosis patients: A complementary 2-DE and LC–MS/MS approach

Nuno Charro, Brian L. Hood, Daniel Faria et al. · Journal of Proteomics · 2010 · 31 citations

Proteomic Technology, Prognostic Biomarkers, Molecular Diagnostic Techniques +14

SELDI-TOF biomarker signatures for cystic fibrosis, asthma and chronic obstructive pulmonary disease

Patrícia Gomes‐Alves, M. Imrie, Robert D. Gray et al. · Clinical Biochemistry · 2009 · 29 citations

Asthma, Inflammation, Prognostic Biomarkers +15

The effect of premature termination codon mutations on <i>CFTR</i> mRNA abundance in human nasal epithelium and intestinal organoids: a basis for read‐through therapies in cystic fibrosis

Luka A. Clarke, Nikhil T Awatade, Verónica Felício et al. · Human Mutation · 2018 · 21 citations · Full text

Cftr Mrna Abundance, Inflammatory Lung Disease, Genetics +19